SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.
Quick Stats
Mar 30, 202640.6
AI Score
HOLD0.88
Volume Ratio
May 12, 2026
Next Earnings
17
+ve Days (30d)
13
-ve Days (30d)
SLS Stock Summary
Last updated Mar 30, 2026
SLS is currently trading at $4.035, positioned above its 200-day moving average of $2.64, indicating a long-term uptrend. The stock has a 52-week range of $0.9516 to $6.14.
Technical Analysis: The 50-day moving average stands at $4.55, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 39.783, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.256, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates SLS at 40.6/100 with a HOLD recommendation.
SLS (SELLAS Life Sciences Group, Inc. Common Stock) Indicators
Last updated Mar 30, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 39.783 |
| CMF (20) | -0.256 |
| ROC (10) | -25.84 |
| ADX (14) | 22.969 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | 0.002 |
| AROONOSC (14) | -100.0 |
| WILLAMS %R (14) | -98.67 |
| MFI (14) | 28.269 |
SLS Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
SLS Price vs Max Options Open Interest
SLS Max Change In Options Open Interest
SLS Options - Sort by Max open Interest (near term)
30th March 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
SLS Daily Out of Money Options - Sort by Max open Interest (near term)
30th March 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
SLS Daily In the Money Options - Sort by Max open Interest (near term)
30th March 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
SLS Most Active Options by Volume(near term)
30th March 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
SELLAS Life Sciences Group, Inc. Common Stock is not trading above both 50 Day and 200 Day SMA which is considered Bearish.
SLS Moving Averages Analysis
SELLAS Life Sciences Group, Inc. Common Stock has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Mar 30, 2026
SLS (SELLAS Life Sciences Group, Inc. Common Stock) Simple Moving Averages
Moving Averages are last updated Mar 30, 2026
| Days | MA |
|---|---|
| 10 | 4.9 |
| 20 | 5.18 |
| 30 | 4.93 |
| 50 | 4.55 |
| 100 | 3.46 |
| 200 | 2.64 |
SLS Fundamental Analysis
| P/E (Forward) | 0 |
| P/E (Trailing) | -- |
| Market Cap ($) | 888.9 million |
| Earnings/Share ($) | -0.23 |
| Net Proft Margin (%) | 0 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -0.2833 |
| EPS Estimate Next Year ($) | -0.18 |
| WallStreet Target Price ($) | 8.6667 |
| Most Recent Quarter |
News: $SLS CEO tweets about a cure before data is analyzed, causing speculation. Predictions of a 73% drop if trial fails, expected announcement in May. Machine learning engineers predict 93-97% chance of success for REGAL trial. Martin Shkreli bearish on stock, others disagree.
Updated 2026-03-10 00:00:02